slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
SUSTAINING LEPROSY CONTROL MEASURES IN THE PUBLIC HEALTH SYSTEM TO ENSURE QUALITY CARE Supported by ANESVAD Foundation, PowerPoint Presentation
Download Presentation
SUSTAINING LEPROSY CONTROL MEASURES IN THE PUBLIC HEALTH SYSTEM TO ENSURE QUALITY CARE Supported by ANESVAD Foundation,

Loading in 2 Seconds...

play fullscreen
1 / 20

SUSTAINING LEPROSY CONTROL MEASURES IN THE PUBLIC HEALTH SYSTEM TO ENSURE QUALITY CARE Supported by ANESVAD Foundation, - PowerPoint PPT Presentation


  • 133 Views
  • Uploaded on

SUSTAINING LEPROSY CONTROL MEASURES IN THE PUBLIC HEALTH SYSTEM TO ENSURE QUALITY CARE Supported by ANESVAD Foundation, Spain implemented by ALERT INDIA, Mumbai, India. INDEX. ANESVAD MISSION AND ITS PRIORITIES 2. ANESVAD INTERVENTIONS IN THE FIELD OF LEPROSY

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'SUSTAINING LEPROSY CONTROL MEASURES IN THE PUBLIC HEALTH SYSTEM TO ENSURE QUALITY CARE Supported by ANESVAD Foundation,' - paul2


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

SUSTAINING LEPROSY CONTROL MEASURES

IN THE PUBLIC HEALTH SYSTEM

TO ENSURE QUALITY CARE

Supported by

ANESVAD Foundation, Spain

implemented by

ALERT INDIA, Mumbai, India

index

INDEX

ANESVAD MISSION AND ITS PRIORITIES

2. ANESVAD INTERVENTIONS IN THE FIELD OF LEPROSY

3. LEPROSY - BASIC CONCEPTS

4. LEPROSY - WORLDWIDE

5. WHY A LEPROSY ELIMINATION ACTION PROGRAMME (LEAP)?

6. LEAP AND ITS COMPONENTS

7. INNOVATIVE APPROACH

anesvad s mission
ANESVAD’s MISSION
  • To contribute to the PROMOTION AND PROTECTION OF
  • HEALTH understood as a fundamental human right:
  • - Defending health as complete physical, mental and social well-being.
  • - Intervening politically, socially, economically and culturally.
  • - Developing alliances with the different actors involved.

ANESVAD Foundation established in 1968 is an independent, non religious and non-governmental organisation for development (NGOD) with the following objective:

anesvad s priorities

ANESVAD’sPRIORITIES

NEGLECTED TROPICAL DISEASES (NTDs)

Leprosy, Buruli Ulcer, Chagas Disease, Dengue Fever and Leishmaniasis

COMMUNITY HEALTH

MOTHER - CHILD HEALTH AND SEXUAL & REPRODUCTIVE HEALTH

HUMAN TRAFFICKING

anesvad and its intervention in the field of leprosy
ANESVAD AND ITS INTERVENTION IN THE FIELD OF LEPROSY
  • 40 years of experience.
  • 1st experience in Culion Island (Philippines) with 36 years of intervention. In 1997 leprosy was eliminated.
  • More than 500 projects to combat leprosy in Asia, America and Africa have been developed.
  • Special focus in Asia, particularly in India supporting leprosy control programmes.

Culion Island, Philippines was a former leprosy colony. Now leprosy free island and a famous tourist destination.

leprosy basic concepts
Is caused by bacillus called Mycobacterium leprae (Hansen, 1874) that causes nerve damage leading to disabilities and deformities.

Least infectious of all communicable diseases.

Completely curable and treatment provided in the early stages averts permanent disability.

Since early 80’s there is a treatment for leprosy MDT (3 drugs) free of charge since 1995.

With minimal training, leprosy can be easily diagnosed based on clinical signs.

Between 1985 and 2008, close to 15 million people were diagnosed and cured with MDT

LEPROSY BASIC CONCEPTS

M.Leprae, a germ causing leprosy

Multidrug therapy (MDT) cures leprosy

leprosy worldwide
LEPROSY WORLDWIDE

17 countries represent 94% of the new leprosy cases detected (NCD) worldwide.

The total of NCD in 2002 was 620.638 while in 2007 were 254.525 cases detected.

Although global leprosy prevalence is declining between 2006-2007, in 10 countries NCD has increased.

The NCD in India represented 54% of the global total leprosy burden in 2007.

Table 1. 17 countries reporting >1000 new cases during 2007

Source: Weekly Epidemiological Record, WHO 2008, 83

why a leprosy elimination action programme leap
WHY A LEPROSY ELIMINATION ACTION PROGRAMME (LEAP)?
  • WHO global strategy for leprosy states that the efforts must focus on integrating leprosy in the general health caresystem and ensure providing quality care and services.
  • Inadequate leprosy care services in the general health care due to absence of an effective referral system.
  • New leprosy cases continue to emerge and a significant number are detected with early disabilities and deformities results in social ostracisms.
  • Leprosy is a chronic disease that requires long-term planning and control measures.
  • The challenge is to deliver a sustainable care and services for leprosy affected persons (new & old cases).
leprosy elimination action programme leap

LEPROSY ELIMINATION ACTION PROGRAMME (LEAP)

WHAT’S LEAP:

LEAP is a strategic programme with defined intervention to ensure the rights of people affected by leprosy through sustained leprosy controlmeasures and enhanced quality care within public health care system.

WHERE IS LEAP IMPLEMENTED:

States of Maharashtra and Chhattisgarh

HOW:

ALERT INDIA + 35 partners with the involvement of the national health care system and the local communities

SUPPORT:

8 years (2005 -2013)

2.262.150 euros (2005-2009)

leap components

LEAP COMPONENTS

Component 1: SPECIAL SELECTIVE DRIVES

Component 2: LEPROSY REFERAL CENTERS

Component 3: CONTINUING MEDICAL EDUCATION

Component 4: EPIDEMIOLOGICAL MONITORING AND EVALUATION (EME)

10

leap component 1

LEAP COMPONENT 1

SELECTIVE SPECIAL DRIVES (SSD)

Train local community members for creating

mass awareness.

Objective

Enablelocal community to promote voluntaryreporting of new cases and to refer them to the adequate services

Main Achievements

5.309.391 people reached through awareness programmes - 3.829 villages / slum pockets

4.847 new leprosy cases detected

leap components1

LEAP COMPONENTS

Component 1: SPECIAL SELECTIVE DRIVES

Component 2: LEPROSY REFERAL CENTERS

Component 3: CONTINUING MEDICAL EDUCATION

Component 4: EPIDEMIOLOGICAL MONITORING AND EVALUATION (EME)

12

leap component 2
LEAP COMPONENT 2

LEPROSY REFERAL CENTRES (LRC)

Train and equip the health care providersat the primary and intermediate level with the necessary skills and tools.

Objective

Improveaccess to quality servicesin the public health system increasing the self-reliance of the health care providers.

Main Achievements

62 LRCs supported - 3385 patients receive disability care and prevention services

State government of Maharashtra has recommended the LRC’s as a “best practice” under health system reforms.

leap components2

LEAP COMPONENTS

  • Component 1: SPECIAL SELECTIVE DRIVES
  • Component 2: LEPROSY REFERAL CENTERS

Component 3: CONTINUING MEDICAL EDUCATION

Component 4: EPIDEMIOLOGICAL MONITORING AND EVALUATION (EME)

14

slide15

LEAP COMPONENT 3

CONTINUING MEDICAL EDUCATION (CME)

Updating the technical knowledge and transferring practical skills to the public and private health care providers using information and communication technology (ICT) tools.

Objective

Add clinical acumen to identify, treat and manage leprosy by health providers and develop links with other health programmes.

Main Achievements

8403 medical and paramedical personnel / students given orientation on leprosy

1.135 private medicine / general practitioners trained in diagnosis and treatment

Diagnostic, treatment and deformity control guides for public health doctors recognised by the Leprosy Division (G.I) and used nationally

leap components3

LEAP COMPONENTS

Component 4: EPIDEMIOLOGICAL MONITORING AND EVALUATION (EME)

  • Component 1: SPECIAL SELECTIVE DRIVES
  • Component 2: LEPROSY REFERAL CENTERS
  • Component 3: CONTINUING MEDICAL EDUCATION

16

leap component 4

LEAP COMPONENT 4

EPIDEMIOLOGICAL MONITORING AND

EVALUATION (EME)

Disease surveillanceand monitoring through

operational research programmes and validating

trend and magnitude of leprosy burden In Mumbai

Objective

Obtain update leprosy related data and trends

Main Achievements

Mumbai leprosy statistics system established

Provide inputs for publications and advocacy for policy change

Involvement of different actors in data collection

innovative approach

LEAP has anintegral approach

tosustainleprosy control andensurerights of leprosy affected persons by . . .

INNOVATIVE APPROACH

facilitating the process of integration of basic leprosy services and specialized referral services within the public health system

promotingan IEC strategy that involves and trains volunteers as spokesperson for leprosy in local communities who suspect and refer new cases of leprosy at an early stage

innovative approach1

INNOVATIVE APPROACH

advocatinga decentralized, guaranteed access to quality care for the leprosy affected persons at the primary and intermediary levels in the public health delivery system and thus aims to secure a right place in health resource planning

developingtrainers and faculty at different levels of Health System for Continuing Medical Education

involvinghealth and development NGOs as partners in leprosy control by imparting the skill and expertise required for under a common strategy for leprosy detection and referral services

thank you very much for your attention
THANK YOU VERY MUCH FOR YOUR ATTENTION

ENSURING RIGHTS OF THE LEPROSY AFFECTED TODAY

20